| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 1.73e-13 | 5 | 58 | 5 | GO:0052871 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 3.62e-12 | 7 | 58 | 5 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 3.62e-12 | 7 | 58 | 5 | GO:0018685 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 4.32e-11 | 10 | 58 | 5 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 4.32e-11 | 10 | 58 | 5 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 4.32e-11 | 10 | 58 | 5 | GO:0102033 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 2.19e-10 | 13 | 58 | 5 | GO:0016713 | |
| GeneOntologyMolecularFunction | aromatase activity | 7.00e-10 | 35 | 58 | 6 | GO:0070330 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 1.64e-09 | 40 | 58 | 6 | GO:0016709 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 5.84e-09 | 49 | 58 | 6 | GO:0016712 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 7.06e-09 | 24 | 58 | 5 | GO:0008392 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 1.33e-08 | 27 | 58 | 5 | GO:0008391 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 4.12e-08 | 115 | 58 | 7 | GO:0004497 | |
| GeneOntologyMolecularFunction | arachidonate binding | 8.54e-08 | 15 | 58 | 4 | GO:0050544 | |
| GeneOntologyMolecularFunction | icosanoid binding | 1.14e-07 | 16 | 58 | 4 | GO:0050542 | |
| GeneOntologyMolecularFunction | icosatetraenoic acid binding | 1.14e-07 | 16 | 58 | 4 | GO:0050543 | |
| GeneOntologyMolecularFunction | long-chain fatty acid binding | 1.25e-06 | 28 | 58 | 4 | GO:0036041 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 1.45e-06 | 194 | 58 | 7 | GO:0016705 | |
| GeneOntologyMolecularFunction | heme binding | 5.55e-06 | 154 | 58 | 6 | GO:0020037 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 7.96e-06 | 164 | 58 | 6 | GO:0046906 | |
| GeneOntologyMolecularFunction | 20-hydroxy-leukotriene B4 omega oxidase activity | 8.29e-06 | 2 | 58 | 2 | GO:0097258 | |
| GeneOntologyMolecularFunction | 20-aldehyde-leukotriene B4 20-monooxygenase activity | 8.29e-06 | 2 | 58 | 2 | GO:0097259 | |
| GeneOntologyMolecularFunction | iron ion binding | 8.53e-06 | 166 | 58 | 6 | GO:0005506 | |
| GeneOntologyMolecularFunction | fatty acid binding | 4.81e-05 | 69 | 58 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | CYP4F8 NDOR1 CYP4B1 DIO3 CYP4F2 CYP4F3 CYP4F12 ALDH6A1 CYP4F11 KMO | 6.40e-05 | 766 | 58 | 10 | GO:0016491 |
| GeneOntologyMolecularFunction | neuroligin family protein binding | 8.25e-05 | 5 | 58 | 2 | GO:0097109 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 2.65e-04 | 107 | 58 | 4 | GO:0033293 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 4.10e-04 | 120 | 58 | 4 | GO:0008013 | |
| GeneOntologyMolecularFunction | water channel activity | 1.10e-03 | 17 | 58 | 2 | GO:0015250 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 1.52e-03 | 20 | 58 | 2 | GO:0035259 | |
| GeneOntologyMolecularFunction | water transmembrane transporter activity | 1.52e-03 | 20 | 58 | 2 | GO:0005372 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 2.02e-03 | 23 | 58 | 2 | GO:0046965 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 5.12e-03 | 239 | 58 | 4 | GO:0031406 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 5.17e-03 | 37 | 58 | 2 | GO:0042923 | |
| GeneOntologyMolecularFunction | organic acid binding | 6.34e-03 | 254 | 58 | 4 | GO:0043177 | |
| GeneOntologyMolecularFunction | amide transmembrane transporter activity | 6.63e-03 | 42 | 58 | 2 | GO:0042887 | |
| GeneOntologyMolecularFunction | transition metal ion binding | ZCCHC14 CYP4F8 CYP4B1 NR4A2 CYP4F2 CYP4F3 CYP4F12 MMP2 CYP4F11 | 6.96e-03 | 1189 | 58 | 9 | GO:0046914 |
| GeneOntologyMolecularFunction | FAD binding | 7.25e-03 | 44 | 58 | 2 | GO:0071949 | |
| GeneOntologyBiologicalProcess | leukotriene B4 catabolic process | 7.36e-13 | 6 | 56 | 5 | GO:0036101 | |
| GeneOntologyBiologicalProcess | leukotriene B4 metabolic process | 2.57e-12 | 7 | 56 | 5 | GO:0036102 | |
| GeneOntologyBiologicalProcess | leukotriene catabolic process | 6.84e-12 | 8 | 56 | 5 | GO:0036100 | |
| GeneOntologyBiologicalProcess | icosanoid catabolic process | 5.61e-11 | 11 | 56 | 5 | GO:1901523 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid catabolic process | 9.59e-11 | 12 | 56 | 5 | GO:0042758 | |
| GeneOntologyBiologicalProcess | fatty acid derivative catabolic process | 3.12e-09 | 22 | 56 | 5 | GO:1901569 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | RELN CYP4F8 CGA NR4A2 DIO3 CYP4F2 CYP4F3 CYP4F12 AQP8 GNB3 CDH3 CYP4F11 ADCYAP1R1 | 1.24e-08 | 641 | 56 | 13 | GO:1901615 |
| GeneOntologyBiologicalProcess | menaquinone catabolic process | 1.90e-08 | 3 | 56 | 3 | GO:0042361 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 4.50e-08 | 73 | 56 | 6 | GO:1901616 | |
| GeneOntologyBiologicalProcess | omega-hydroxylase P450 pathway | 4.78e-08 | 14 | 56 | 4 | GO:0097267 | |
| GeneOntologyBiologicalProcess | menaquinone metabolic process | 7.57e-08 | 4 | 56 | 3 | GO:0009233 | |
| GeneOntologyBiologicalProcess | phylloquinone metabolic process | 7.57e-08 | 4 | 56 | 3 | GO:0042374 | |
| GeneOntologyBiologicalProcess | phylloquinone catabolic process | 7.57e-08 | 4 | 56 | 3 | GO:0042376 | |
| GeneOntologyBiologicalProcess | vitamin K catabolic process | 7.57e-08 | 4 | 56 | 3 | GO:0042377 | |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 8.55e-08 | 41 | 56 | 5 | GO:0006691 | |
| GeneOntologyBiologicalProcess | prostaglandin catabolic process | 3.77e-07 | 6 | 56 | 3 | GO:1905344 | |
| GeneOntologyBiologicalProcess | prostanoid catabolic process | 3.77e-07 | 6 | 56 | 3 | GO:0062232 | |
| GeneOntologyBiologicalProcess | arachidonate metabolic process | 1.12e-06 | 68 | 56 | 5 | GO:0019369 | |
| GeneOntologyBiologicalProcess | fatty acid derivative metabolic process | 2.86e-06 | 82 | 56 | 5 | GO:1901568 | |
| GeneOntologyBiologicalProcess | vitamin K metabolic process | 3.08e-06 | 11 | 56 | 3 | GO:0042373 | |
| GeneOntologyBiologicalProcess | fat-soluble vitamin catabolic process | 4.10e-06 | 12 | 56 | 3 | GO:0042363 | |
| GeneOntologyBiologicalProcess | organic acid catabolic process | 8.57e-06 | 272 | 56 | 7 | GO:0016054 | |
| GeneOntologyBiologicalProcess | carboxylic acid catabolic process | 8.57e-06 | 272 | 56 | 7 | GO:0046395 | |
| GeneOntologyBiologicalProcess | signal release from synapse | 1.45e-05 | 195 | 56 | 6 | GO:0099643 | |
| GeneOntologyBiologicalProcess | neurotransmitter secretion | 1.45e-05 | 195 | 56 | 6 | GO:0007269 | |
| GeneOntologyBiologicalProcess | vitamin catabolic process | 1.50e-05 | 18 | 56 | 3 | GO:0009111 | |
| GeneOntologyBiologicalProcess | fatty acid catabolic process | 1.57e-05 | 116 | 56 | 5 | GO:0009062 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid metabolic process | 2.16e-05 | 124 | 56 | 5 | GO:0001676 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 2.44e-05 | 21 | 56 | 3 | GO:0042182 | |
| GeneOntologyBiologicalProcess | unsaturated fatty acid metabolic process | 2.52e-05 | 128 | 56 | 5 | GO:0033559 | |
| GeneOntologyBiologicalProcess | vocalization behavior | 3.68e-05 | 24 | 56 | 3 | GO:0071625 | |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 4.15e-05 | 142 | 56 | 5 | GO:0006690 | |
| GeneOntologyBiologicalProcess | phenol-containing compound metabolic process | 4.15e-05 | 142 | 56 | 5 | GO:0018958 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid catabolic process | 4.59e-05 | 145 | 56 | 5 | GO:0072329 | |
| GeneOntologyBiologicalProcess | signal release | 6.06e-05 | 653 | 56 | 9 | GO:0023061 | |
| GeneOntologyBiologicalProcess | neurotransmitter transport | 7.10e-05 | 259 | 56 | 6 | GO:0006836 | |
| GeneOntologyBiologicalProcess | secretion | CACNA1E NCOA6 NRXN3 NRXN2 CGA DGKI CYP4F2 AQP8 CADPS2 LTBP4 AQP5 KMO | 8.64e-05 | 1221 | 56 | 12 | GO:0046903 |
| GeneOntologyBiologicalProcess | postsynaptic density assembly | 1.07e-04 | 34 | 56 | 3 | GO:0097107 | |
| GeneOntologyBiologicalProcess | thyroid hormone metabolic process | 1.07e-04 | 34 | 56 | 3 | GO:0042403 | |
| GeneOntologyBiologicalProcess | vitamin E metabolic process | 1.08e-04 | 6 | 56 | 2 | GO:0042360 | |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | 1.28e-04 | 180 | 56 | 5 | GO:0120254 | |
| GeneOntologyBiologicalProcess | small molecule catabolic process | 1.37e-04 | 421 | 56 | 7 | GO:0044282 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization assembly | 2.32e-04 | 44 | 56 | 3 | GO:0098698 | |
| GeneOntologyBiologicalProcess | excitatory synapse assembly | 2.65e-04 | 46 | 56 | 3 | GO:1904861 | |
| GeneOntologyBiologicalProcess | learning | 2.73e-04 | 212 | 56 | 5 | GO:0007612 | |
| GeneOntologyBiologicalProcess | post-embryonic animal morphogenesis | 3.21e-04 | 10 | 56 | 2 | GO:0009886 | |
| GeneOntologyBiologicalProcess | fat-soluble vitamin metabolic process | 3.60e-04 | 51 | 56 | 3 | GO:0006775 | |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 3.81e-04 | 126 | 56 | 4 | GO:0033555 | |
| GeneOntologyBiologicalProcess | postsynaptic density protein 95 clustering | 3.92e-04 | 11 | 56 | 2 | GO:0097119 | |
| GeneOntologyBiologicalProcess | vitamin metabolic process | 4.68e-04 | 133 | 56 | 4 | GO:0006766 | |
| GeneOntologyBiologicalProcess | learning or memory | 5.09e-04 | 373 | 56 | 6 | GO:0007611 | |
| GeneOntologyBiologicalProcess | postsynaptic density organization | 5.26e-04 | 58 | 56 | 3 | GO:0097106 | |
| GeneOntologyBiologicalProcess | digestive tract morphogenesis | 5.53e-04 | 59 | 56 | 3 | GO:0048546 | |
| GeneOntologyBiologicalProcess | lipid catabolic process | 5.77e-04 | 382 | 56 | 6 | GO:0016042 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 5.99e-04 | 142 | 56 | 4 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 5.99e-04 | 142 | 56 | 4 | GO:0098659 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | 7.56e-04 | 731 | 56 | 8 | GO:0032787 | |
| GeneOntologyBiologicalProcess | presynaptic modulation of chemical synaptic transmission | 8.03e-04 | 67 | 56 | 3 | GO:0099171 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 8.48e-04 | 16 | 56 | 2 | GO:0007158 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization organization | 9.51e-04 | 71 | 56 | 3 | GO:0099084 | |
| GeneOntologyBiologicalProcess | layer formation in cerebral cortex | 9.59e-04 | 17 | 56 | 2 | GO:0021819 | |
| GeneOntologyBiologicalProcess | export from cell | 9.71e-04 | 1153 | 56 | 10 | GO:0140352 | |
| GeneOntologyBiologicalProcess | cognition | 9.80e-04 | 423 | 56 | 6 | GO:0050890 | |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 1.20e-03 | 171 | 56 | 4 | GO:0048593 | |
| GeneOntologyBiologicalProcess | negative regulation of defense response to virus | 1.20e-03 | 19 | 56 | 2 | GO:0050687 | |
| GeneOntologyBiologicalProcess | fatty acid metabolic process | 1.52e-03 | 461 | 56 | 6 | GO:0006631 | |
| GeneOntologyBiologicalProcess | spinal cord patterning | 1.62e-03 | 22 | 56 | 2 | GO:0021511 | |
| GeneOntologyBiologicalProcess | epoxygenase P450 pathway | 1.62e-03 | 22 | 56 | 2 | GO:0019373 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | CYP4F8 CYP4B1 SLC5A6 CYP4F2 CYP4F3 CYP4F12 ALDH6A1 CYP4F11 KMO | 1.76e-03 | 1035 | 56 | 9 | GO:0019752 |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 2.01e-03 | 92 | 56 | 3 | GO:0051966 | |
| GeneOntologyBiologicalProcess | positive regulation of small GTPase mediated signal transduction | 2.01e-03 | 92 | 56 | 3 | GO:0051057 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | CYP4F8 CYP4B1 SLC5A6 CYP4F2 CYP4F3 CYP4F12 ALDH6A1 CYP4F11 KMO | 2.04e-03 | 1058 | 56 | 9 | GO:0043436 |
| GeneOntologyBiologicalProcess | postsynapse assembly | 2.07e-03 | 93 | 56 | 3 | GO:0099068 | |
| GeneOntologyBiologicalProcess | secretion by cell | 2.12e-03 | 1064 | 56 | 9 | GO:0032940 | |
| GeneOntologyBiologicalProcess | organic acid metabolic process | CYP4F8 CYP4B1 SLC5A6 CYP4F2 CYP4F3 CYP4F12 ALDH6A1 CYP4F11 KMO | 2.12e-03 | 1064 | 56 | 9 | GO:0006082 |
| GeneOntologyBiologicalProcess | eye morphogenesis | 2.28e-03 | 204 | 56 | 4 | GO:0048592 | |
| GeneOntologyBiologicalProcess | positive regulation of transport | 2.37e-03 | 1081 | 56 | 9 | GO:0051050 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | 2.42e-03 | 684 | 56 | 7 | GO:0010817 | |
| GeneOntologyBiologicalProcess | behavior | 2.65e-03 | 891 | 56 | 8 | GO:0007610 | |
| GeneOntologyCellularComponent | apical plasma membrane | CYP4F8 SLC5A6 CYP4F2 CYP4F3 CYP4F12 AQP8 ATP1B3 AQP5 CYP4F11 CRB1 | 5.85e-07 | 487 | 56 | 10 | GO:0016324 |
| GeneOntologyCellularComponent | apical part of cell | CYP4F8 SLC5A6 CYP4F2 CYP4F3 CYP4F12 AQP8 ATP1B3 AQP5 CYP4F11 CRB1 | 3.39e-06 | 592 | 56 | 10 | GO:0045177 |
| MousePheno | abnormal feces composition | 2.87e-08 | 98 | 46 | 7 | MP:0003868 | |
| Domain | Cyt_P450_E_grp-I | 4.10e-09 | 45 | 56 | 6 | IPR002401 | |
| Domain | Cyt_P450_CS | 1.14e-08 | 53 | 56 | 6 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 1.78e-08 | 57 | 56 | 6 | PS00086 | |
| Domain | - | 1.98e-08 | 58 | 56 | 6 | 1.10.630.10 | |
| Domain | p450 | 1.98e-08 | 58 | 56 | 6 | PF00067 | |
| Domain | Cyt_P450 | 2.44e-08 | 60 | 56 | 6 | IPR001128 | |
| Domain | Syndecan | 1.84e-04 | 7 | 56 | 2 | PF01034 | |
| Domain | Syndecan/Neurexin_dom | 1.84e-04 | 7 | 56 | 2 | IPR027789 | |
| Domain | LAM_G_DOMAIN | 2.00e-04 | 38 | 56 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 2.33e-04 | 40 | 56 | 3 | PF02210 | |
| Domain | LamG | 3.10e-04 | 44 | 56 | 3 | SM00282 | |
| Domain | MIP_CS | 3.91e-04 | 10 | 56 | 2 | IPR022357 | |
| Domain | EGF_3 | 6.85e-04 | 235 | 56 | 5 | PS50026 | |
| Domain | EGF | 6.85e-04 | 235 | 56 | 5 | SM00181 | |
| Domain | Laminin_G | 7.01e-04 | 58 | 56 | 3 | IPR001791 | |
| Domain | MIP | 7.85e-04 | 14 | 56 | 2 | PS00221 | |
| Domain | MIP | 7.85e-04 | 14 | 56 | 2 | PF00230 | |
| Domain | Neurexin-like | 7.85e-04 | 14 | 56 | 2 | IPR003585 | |
| Domain | 4.1m | 7.85e-04 | 14 | 56 | 2 | SM00294 | |
| Domain | EGF-like_dom | 8.88e-04 | 249 | 56 | 5 | IPR000742 | |
| Domain | MIP | 9.04e-04 | 15 | 56 | 2 | IPR000425 | |
| Domain | - | 9.04e-04 | 15 | 56 | 2 | 1.20.1080.10 | |
| Domain | Aquaporin-like | 9.04e-04 | 15 | 56 | 2 | IPR023271 | |
| Domain | EGF_1 | 9.88e-04 | 255 | 56 | 5 | PS00022 | |
| Domain | EGF-like_CS | 1.10e-03 | 261 | 56 | 5 | IPR013032 | |
| Domain | EGF_2 | 1.17e-03 | 265 | 56 | 5 | PS01186 | |
| Domain | - | 2.91e-03 | 95 | 56 | 3 | 2.60.120.200 | |
| Domain | ASX_HYDROXYL | 3.36e-03 | 100 | 56 | 3 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.96e-03 | 106 | 56 | 3 | IPR000152 | |
| Domain | EGF | 6.41e-03 | 126 | 56 | 3 | PF00008 | |
| Domain | C2 | 7.13e-03 | 131 | 56 | 3 | PF00168 | |
| Domain | C2 | 8.06e-03 | 137 | 56 | 3 | SM00239 | |
| Domain | C2 | 8.89e-03 | 142 | 56 | 3 | PS50004 | |
| Pathway | REACTOME_EICOSANOIDS | 4.39e-13 | 12 | 42 | 6 | M27129 | |
| Pathway | REACTOME_EICOSANOIDS | 4.39e-13 | 12 | 42 | 6 | MM14845 | |
| Pathway | REACTOME_FATTY_ACIDS | 2.36e-12 | 15 | 42 | 6 | M27126 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 8.71e-12 | 18 | 42 | 6 | MM14843 | |
| Pathway | REACTOME_FATTY_ACIDS | 8.71e-12 | 18 | 42 | 6 | MM14841 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 8.18e-11 | 25 | 42 | 6 | MM14858 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 3.60e-10 | 14 | 42 | 5 | MM15842 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 3.61e-09 | 21 | 42 | 5 | M27137 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 2.37e-08 | 61 | 42 | 6 | MM14861 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 2.62e-08 | 62 | 42 | 6 | M39653 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 3.18e-08 | 64 | 42 | 6 | M5650 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 3.31e-08 | 12 | 42 | 4 | M27128 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 3.84e-08 | 66 | 42 | 6 | MM14839 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 4.10e-08 | 33 | 42 | 5 | MM15918 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 4.10e-08 | 33 | 42 | 5 | MM15963 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 5.90e-07 | 104 | 42 | 6 | M738 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 6.24e-07 | 105 | 42 | 6 | MM14842 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 8.16e-07 | 59 | 42 | 5 | M27140 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 3.99e-06 | 11 | 42 | 3 | MM14863 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 1.03e-05 | 170 | 42 | 6 | MM15573 | |
| Pathway | WP_TRYPTOPHAN_METABOLISM | 1.20e-05 | 48 | 42 | 4 | MM15902 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 1.57e-05 | 183 | 42 | 6 | M39588 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 4.32e-05 | 219 | 42 | 6 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 4.43e-05 | 220 | 42 | 6 | M10320 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 1.68e-04 | 176 | 42 | 5 | M27854 | |
| Pathway | REACTOME_AQUAPORIN_MEDIATED_TRANSPORT | 2.25e-04 | 40 | 42 | 3 | MM15115 | |
| Pathway | REACTOME_THYROXINE_BIOSYNTHESIS | 3.08e-04 | 9 | 42 | 2 | MM14833 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY | 3.08e-04 | 9 | 42 | 2 | M39819 | |
| Pathway | REACTOME_THYROXINE_BIOSYNTHESIS | 3.84e-04 | 10 | 42 | 2 | M27120 | |
| Pathway | REACTOME_AQUAPORIN_MEDIATED_TRANSPORT | 4.91e-04 | 52 | 42 | 3 | M920 | |
| Pathway | REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS | 6.62e-04 | 13 | 42 | 2 | MM15095 | |
| Pathway | REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS | 6.62e-04 | 13 | 42 | 2 | M911 | |
| Pathway | REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES | 7.66e-04 | 245 | 42 | 5 | MM15403 | |
| Pathway | REACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES | 1.15e-03 | 17 | 42 | 2 | MM14829 | |
| Pathway | REACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES | 1.29e-03 | 18 | 42 | 2 | M27118 | |
| Pathway | WP_GDNFRET_SIGNALING_AXIS | 1.93e-03 | 22 | 42 | 2 | MM15887 | |
| Pathway | WP_GDNFRET_SIGNALING_AXIS | 2.11e-03 | 23 | 42 | 2 | M39814 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | 2.17e-03 | 620 | 42 | 7 | MM15193 | |
| Pathway | WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS | 2.90e-03 | 27 | 42 | 2 | M45550 | |
| Pubmed | 6.48e-14 | 6 | 58 | 5 | 9068972 | ||
| Pubmed | 6.96e-12 | 4 | 58 | 4 | 22665481 | ||
| Pubmed | Expression and catalytic activity of mouse leukotriene B4 omega-hydroxylase, CYP4F14. | 6.96e-12 | 4 | 58 | 4 | 11185557 | |
| Pubmed | Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11. | 6.96e-12 | 4 | 58 | 4 | 18065749 | |
| Pubmed | 3.48e-11 | 5 | 58 | 4 | 22969154 | ||
| Pubmed | Cytochrome P4504f, a potential therapeutic target limiting neuroinflammation. | 3.48e-11 | 5 | 58 | 4 | 21466787 | |
| Pubmed | 2.43e-10 | 7 | 58 | 4 | 22160543 | ||
| Pubmed | 1.99e-09 | 70 | 58 | 6 | 15128046 | ||
| Pubmed | Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. | 1.12e-08 | 44 | 58 | 5 | 12745259 | |
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 8.77e-08 | 6 | 58 | 3 | 12827191 | |
| Pubmed | 1.08e-06 | 46 | 58 | 4 | 25209997 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 24138531 | ||
| Pubmed | Expression of CYP4F2 in human liver and kidney: assessment using targeted peptide antibodies. | 2.73e-06 | 2 | 58 | 2 | 18662666 | |
| Pubmed | Expression and physiological function of CYP4F subfamily in human eosinophils. | 2.73e-06 | 2 | 58 | 2 | 17980168 | |
| Pubmed | Cloning and expression of a novel form of leukotriene B4 omega-hydroxylase from human liver. | 2.73e-06 | 2 | 58 | 2 | 8026587 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 16112640 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 15364545 | ||
| Pubmed | 8.17e-06 | 76 | 58 | 4 | 22323595 | ||
| Pubmed | Endogenous β-neurexins on axons and within synapses show regulated dynamic behavior. | 8.19e-06 | 3 | 58 | 2 | 34133920 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 38891114 | ||
| Pubmed | Differential expression and inhibitory effects of aquaporins on the development of adenomyosis. | 8.19e-06 | 3 | 58 | 2 | 32901888 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 15647389 | ||
| Pubmed | Human CYP4F3s are the main catalysts in the oxidation of fatty acid epoxides. | 8.19e-06 | 3 | 58 | 2 | 15145985 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 30858964 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 28013231 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 16406382 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 31812984 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 29203120 | ||
| Pubmed | Nkx2.3 transcription factor is a key regulator of mucous cell identity in salivary glands. | 8.19e-06 | 3 | 58 | 2 | 38311164 | |
| Pubmed | Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. | 8.19e-06 | 3 | 58 | 2 | 12036300 | |
| Pubmed | β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling. | 8.19e-06 | 3 | 58 | 2 | 26213384 | |
| Pubmed | Neurexin gene family variants as risk factors for autism spectrum disorder. | 8.19e-06 | 3 | 58 | 2 | 29045040 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 31005376 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 38571813 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 35173587 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 22531681 | ||
| Pubmed | Structural Basis for Mutations of Human Aquaporins Associated to Genetic Diseases. | 8.19e-06 | 3 | 58 | 2 | 29799470 | |
| Pubmed | Neurexins are differentially expressed in the embryonic nervous system of mice. | 8.19e-06 | 3 | 58 | 2 | 7722633 | |
| Pubmed | Regulated Dynamic Trafficking of Neurexins Inside and Outside of Synaptic Terminals. | 8.19e-06 | 3 | 58 | 2 | 26446217 | |
| Pubmed | Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. | 8.19e-06 | 3 | 58 | 2 | 11944992 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 33058888 | ||
| Pubmed | Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules. | 8.19e-06 | 3 | 58 | 2 | 17035546 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 9448462 | ||
| Pubmed | Deletion of α-neurexin II results in autism-related behaviors in mice. | 8.19e-06 | 3 | 58 | 2 | 25423136 | |
| Pubmed | Postsynaptic N-methyl-D-aspartate receptor function requires alpha-neurexins. | 1.64e-05 | 4 | 58 | 2 | 14983056 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 32706374 | ||
| Pubmed | Distribution of aquaporin water channels AQP1 and AQP5 in the ductal system of the human pancreas. | 1.64e-05 | 4 | 58 | 2 | 12801959 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 8786425 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 17347997 | ||
| Pubmed | Neurexins cluster Ca2+ channels within the presynaptic active zone. | 1.64e-05 | 4 | 58 | 2 | 32134527 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 19901964 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 35385735 | ||
| Pubmed | Neurexins regulate presynaptic GABAB-receptors at central synapses. | 1.64e-05 | 4 | 58 | 2 | 33888718 | |
| Pubmed | 1.80e-05 | 193 | 58 | 5 | 19343046 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 28472659 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 36709330 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 18063683 | ||
| Pubmed | A novel mode of tangential migration of cortical projection neurons. | 2.72e-05 | 5 | 58 | 2 | 16901480 | |
| Pubmed | A Unique "Reversed" Migration of Neurons in the Developing Claustrum. | 2.72e-05 | 5 | 58 | 2 | 36631266 | |
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 20537373 | ||
| Pubmed | Animal models of gene-environment interactions in schizophrenia. | 2.72e-05 | 5 | 58 | 2 | 19379776 | |
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 29515120 | ||
| Pubmed | Aquaporin expression patterns in the developing mouse salivary gland. | 2.72e-05 | 5 | 58 | 2 | 20121927 | |
| Pubmed | Neuroligins and neurexins link synaptic function to cognitive disease. | 2.72e-05 | 5 | 58 | 2 | 18923512 | |
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 18577768 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 9223334 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 25809189 | ||
| Pubmed | Structures, alternative splicing, and neurexin binding of multiple neuroligins. | 4.08e-05 | 6 | 58 | 2 | 8576240 | |
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 30683685 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 25308109 | ||
| Pubmed | 5.71e-05 | 7 | 58 | 2 | 9822113 | ||
| Pubmed | Heterogeneous nuclear ribonucleoprotein U (HNRNPU) safeguards the developing mouse cortex. | 6.35e-05 | 46 | 58 | 3 | 35864088 | |
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 7.60e-05 | 8 | 58 | 2 | 30871858 | |
| Pubmed | 7.60e-05 | 8 | 58 | 2 | 37591863 | ||
| Pubmed | Myh10 deficiency leads to defective extracellular matrix remodeling and pulmonary disease. | 9.18e-05 | 52 | 58 | 3 | 30389913 | |
| Pubmed | 9.77e-05 | 9 | 58 | 2 | 34919427 | ||
| Pubmed | Aquaporin molecular biology and clinical abnormalities of the water transport channels. | 9.77e-05 | 9 | 58 | 2 | 9757370 | |
| Pubmed | 9.77e-05 | 9 | 58 | 2 | 9707552 | ||
| Pubmed | Expression of mRNAs of the aquaporin family in mouse oocytes and embryos. | 1.22e-04 | 10 | 58 | 2 | 10788316 | |
| Pubmed | Aquaporin-6: An intracellular vesicle water channel protein in renal epithelia. | 1.22e-04 | 10 | 58 | 2 | 10318966 | |
| Pubmed | 1.22e-04 | 10 | 58 | 2 | 12031518 | ||
| Pubmed | mRNAs encoding aquaporins are present during murine preimplantation development. | 1.22e-04 | 10 | 58 | 2 | 11066060 | |
| Pubmed | 1.46e-04 | 300 | 58 | 5 | 19086053 | ||
| Pubmed | 1.49e-04 | 11 | 58 | 2 | 29033846 | ||
| Pubmed | 1.49e-04 | 11 | 58 | 2 | 7530250 | ||
| Pubmed | 1.49e-04 | 11 | 58 | 2 | 21251984 | ||
| Pubmed | Roles of aquaporin-3 water channels in volume-regulatory water flow in a human epithelial cell line. | 1.49e-04 | 11 | 58 | 2 | 16596446 | |
| Pubmed | Novel variants in human Aquaporin-4 reduce cellular water permeability. | 1.49e-04 | 11 | 58 | 2 | 18511455 | |
| Pubmed | 1.49e-04 | 11 | 58 | 2 | 1510932 | ||
| Pubmed | Mercury-sensitive residues and pore site in AQP3 water channel. | 1.49e-04 | 11 | 58 | 2 | 9369468 | |
| Pubmed | Appearance of water channels in Xenopus oocytes expressing red cell CHIP28 protein. | 1.49e-04 | 11 | 58 | 2 | 1373524 | |
| Pubmed | Functional characterization and localization of AQP3 in the human colon. | 1.49e-04 | 11 | 58 | 2 | 10510269 | |
| Pubmed | 1.49e-04 | 11 | 58 | 2 | 14701836 | ||
| Pubmed | Mechanism of selectivity in aquaporins and aquaglyceroporins. | 1.49e-04 | 11 | 58 | 2 | 18202181 | |
| Pubmed | Functional characterization of human aquaporin 9 as a facilitative glycerol carrier. | 1.49e-04 | 11 | 58 | 2 | 18762715 | |
| Pubmed | Functional and molecular characterization of the human neutral solute channel aquaporin-9. | 1.49e-04 | 11 | 58 | 2 | 10564231 | |
| Pubmed | 1.49e-04 | 11 | 58 | 2 | 18501347 | ||
| Pubmed | Cloning and functional expression of human aquaporin8 cDNA and analysis of its gene. | 1.49e-04 | 11 | 58 | 2 | 9806845 | |
| Pubmed | Structural determinants of water permeation through aquaporin-1. | 1.49e-04 | 11 | 58 | 2 | 11034202 | |
| Pubmed | 1.49e-04 | 11 | 58 | 2 | 22649246 | ||
| Cytoband | 19p13.1 | 3.18e-05 | 48 | 58 | 3 | 19p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 6.45e-05 | 797 | 58 | 7 | chr19p13 | |
| GeneFamily | Cytochrome P450 family 4 | 1.72e-10 | 36 | 41 | 6 | 1003 | |
| GeneFamily | Aquaporins | 4.49e-04 | 14 | 41 | 2 | 305 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.01e-03 | 36 | 41 | 2 | 823 | |
| Coexpression | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN | 6.72e-10 | 20 | 58 | 5 | MM1104 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-07 | 185 | 58 | 6 | 3a4ae836e882e8d29eb0a2dfab5677f10f2d365f | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-07 | 185 | 58 | 6 | 224f0b022c21dd40bf1f7503f00b3107ef958975 | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.66e-07 | 188 | 58 | 6 | dc52dd2957be3f40001f0a56f3d9ac9d66ea466e | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.66e-07 | 188 | 58 | 6 | 2ef08313087e91985bcffc46c3798470cdeec49c | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.66e-07 | 188 | 58 | 6 | 1f1604b6dc0a8ad0be3d9aac0bef448459c22465 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.77e-07 | 190 | 58 | 6 | f50b9814a1beac67dc042a8c27dfd085ceeda3a6 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.77e-07 | 190 | 58 | 6 | a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.77e-07 | 190 | 58 | 6 | 57c136bf6d7feafb4a220877bed0cc8fdf314db2 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.39e-07 | 200 | 58 | 6 | 858421b91f5207b7934b5c219752cb9322a3da31 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.39e-07 | 200 | 58 | 6 | a7022762c1d8aedb7b3e9605873b1e68b9907b35 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.39e-07 | 200 | 58 | 6 | 2131c8e7fa054b79906eaf60536da892438b09cd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-06 | 163 | 58 | 5 | 2d6fd2562d78be9f83fa35d811eb7e27eb8cc5d1 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-06 | 169 | 58 | 5 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-06 | 176 | 58 | 5 | fee4e0f32aaf77294040c7af6c1f503571750d43 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-06 | 176 | 58 | 5 | f25251abd4ef9fb077a978f9f9f658af58e4e0d2 | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-06 | 185 | 58 | 5 | 90caab8d9361a541c5d5121c97c3f1cdffeeae4a | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-06 | 187 | 58 | 5 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-06 | 187 | 58 | 5 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-06 | 187 | 58 | 5 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.62e-06 | 188 | 58 | 5 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.99e-06 | 191 | 58 | 5 | 2c51850f5c559d665b8a27a12b75af9ed58dffe1 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-06 | 191 | 58 | 5 | b9ae5af426e7a1f2652a47700bb168371bd2dec6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.25e-06 | 193 | 58 | 5 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.39e-06 | 194 | 58 | 5 | 83863da11dfbe59b2d0a2c08db40b537c150588c | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.52e-06 | 195 | 58 | 5 | bad7f2162000f29488b3c4b903dcac9a818621f7 | |
| ToppCell | distal-1-mesenchymal-Lipofibroblast|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.10e-06 | 199 | 58 | 5 | a8293db3c42a8d30897858b49aae7acfc18663ba | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.25e-06 | 200 | 58 | 5 | 347a510755374c6a66acee326565dfc447993f18 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.25e-06 | 200 | 58 | 5 | ce969c958a31145bbfe315a9a865d7900ecc9549 | |
| ToppCell | Control-Neutrophil|Control / Disease condition and Cell class | 2.21e-05 | 126 | 58 | 4 | 450c01d89714feee6529680ec3ce69067a54b37c | |
| ToppCell | Control-Neutrophil-|Control / Disease condition and Cell class | 2.21e-05 | 126 | 58 | 4 | 65fff5ec2296272e94f44546606587833191dd82 | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|kidney / Disease (COVID-19 only), tissue and cell type | 2.43e-05 | 129 | 58 | 4 | 57b705106aec7bbfc587de1ccd4f2335fc44dd6f | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.77e-05 | 161 | 58 | 4 | b81b346309f3facbfbebd91cae4c5b33c7bd24ef | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.77e-05 | 161 | 58 | 4 | 0605134a342d74ae81f33700d6ddfcd6e03aeb7b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.91e-05 | 162 | 58 | 4 | d28b2ea1d2c8f3c6a107991573471b6d0c49c4ae | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.91e-05 | 162 | 58 | 4 | 5bbd7130d4dad9035e73a439dda568195c136f31 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.91e-05 | 162 | 58 | 4 | eed223e61c8162a2fe004ab4e09de5e037be7553 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.91e-05 | 162 | 58 | 4 | e35ddce830e20ebeac1a2c405293fc4a5323dd4a | |
| ToppCell | Ionocyte-iono-3|World / Class top | 6.49e-05 | 166 | 58 | 4 | 9c4a780f8af46d7552077c7a0ae0ab1b2413e5d4 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.64e-05 | 167 | 58 | 4 | 17c653b46507c8bb85da95836ae72a6015336142 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.96e-05 | 169 | 58 | 4 | db73dae011ff3749b3706e50ab46d03b775dd6bb | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.96e-05 | 169 | 58 | 4 | 97b7047b87ce0052d8580565c9b44fd2aa6f0d5c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.96e-05 | 169 | 58 | 4 | 1a684471dbda42e1470e5a889648666e14f25982 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.96e-05 | 169 | 58 | 4 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 170 | 58 | 4 | 749144a1a869a6bf9acdd227184319083367dc3f | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 170 | 58 | 4 | 25d60a62e8f99c31ab64fe6a0c07ccca3df1a7ee | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.45e-05 | 172 | 58 | 4 | 422d311bba2dd5d8bece4e96ee8c86e78086b62d | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-plasmacytoid_dendritic_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.45e-05 | 172 | 58 | 4 | 1abb6fbb28c8aff384540493d0f70eeacaa751f4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1-3_PAX6_NABP1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.45e-05 | 172 | 58 | 4 | 4ae0a3ba4660fc9292b7e9a3087a25a3349d8965 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.62e-05 | 173 | 58 | 4 | e05cddf5bf63cf419343ff229453327519765be8 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Mesenchymal_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.62e-05 | 173 | 58 | 4 | b43817a6b1ed8d6b5366702343be4311c0d52d83 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.62e-05 | 173 | 58 | 4 | 74ad5ed33821b8816c9c8e67c50ee4496ba18e2f | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.79e-05 | 174 | 58 | 4 | c529f3674b784f872f4387ffdeb46aecb619976b | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.88e-05 | 180 | 58 | 4 | b294f9db1e2ff51c94cde64fae4c2b057c0030a1 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.07e-05 | 181 | 58 | 4 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 9.07e-05 | 181 | 58 | 4 | 88f6f56f5f58b479d5db91b32c45934c045f88ea | |
| ToppCell | Hippocampus-Neuronal-Inhibitory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.27e-05 | 182 | 58 | 4 | b54ae650c04dfd0759c5f5e752b9bf684dd36516 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.67e-05 | 184 | 58 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.67e-05 | 184 | 58 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.67e-05 | 184 | 58 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.87e-05 | 185 | 58 | 4 | eeb6f55a6f79adf80247baa2c4b0df44553557ad | |
| ToppCell | facs-Trachea-nan-24m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.87e-05 | 185 | 58 | 4 | dec60254204014083ff3b4aec0cc75410950a486 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-erythroid-mid_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.87e-05 | 185 | 58 | 4 | e9059cefcdf0972ec90793b1dd34c3292b17a061 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.87e-05 | 185 | 58 | 4 | 3d73b3e0bceb192257e5cfbe64b7ccb379b6e22d | |
| ToppCell | facs-Trachea-nan-24m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.87e-05 | 185 | 58 | 4 | 201465dc0d7aa0336a36d37805cae1155a5adfe1 | |
| ToppCell | facs-Trachea-nan-24m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.87e-05 | 185 | 58 | 4 | 334f006c3ef33338ff8d649309d3f448733a3a99 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 186 | 58 | 4 | d1d01ce46e62944aa9864eda47e8401b5f0d2bdc | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 186 | 58 | 4 | 2cae34336f184f971f7c8684cc27c23a4e7369ed | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 186 | 58 | 4 | 37860daeecd6d412bd3797f30496a56da667fbd1 | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.01e-04 | 186 | 58 | 4 | b80aaeebc03a318052076d2f02c123f5ddc5e73a | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 186 | 58 | 4 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.01e-04 | 186 | 58 | 4 | 8a8ed1502542d4895cba3fd5d534256206578716 | |
| ToppCell | Tuft|World / Class top | 1.01e-04 | 186 | 58 | 4 | f4d83f15ab7b49c0920a322cd832413ece7c9948 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 186 | 58 | 4 | 90d53c2597a9f3a2b39afba75adfc54f1ca0a4db | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 186 | 58 | 4 | 60830822d3de3147816693404fd03392e04c2b8e | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 186 | 58 | 4 | baebeffdd426ce767190ddefc857cc78e6a58d36 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-04 | 187 | 58 | 4 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 187 | 58 | 4 | 0f90bce2087aecfdbb377e6f46c6e468efbb6e28 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 187 | 58 | 4 | 76c957b2976d38adb45e07bcf96c689442e1fc20 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 187 | 58 | 4 | 9c9ae8725905ba0cfe407878006ed06c2480fb72 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 187 | 58 | 4 | 90a1078b0303799fba5d2ca4fa12076fd75b78b1 | |
| ToppCell | Tuft-tuft-2|World / Class top | 1.03e-04 | 187 | 58 | 4 | 4ec6eee866619dfe13c84f5d2e812bb380d37139 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 187 | 58 | 4 | 9e9460e57cdc9cd0a0de2866b140e06d0bc19a8f | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.05e-04 | 188 | 58 | 4 | 5bc1537e079c7435196c163bff5f639ea392a33a | |
| ToppCell | Endothelial-Endothelial-E|Endothelial / shred on cell class and cell subclass (v4) | 1.05e-04 | 188 | 58 | 4 | 2777eb7689b271c199021fe7d9db88ccebff14de | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-04 | 188 | 58 | 4 | 524a12f433c7b6f33fad36c0716afa06cd3235e9 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-04 | 188 | 58 | 4 | d2610b81b3c7f22977b5e2137b1f61410fc4ef16 | |
| ToppCell | EC-Sinusoidal_ECs|World / Lineage and Cell class | 1.07e-04 | 189 | 58 | 4 | 9a0956c8a7069ba3bd0fa56d052d6e514453e578 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-04 | 189 | 58 | 4 | 06c44746fa4f02e6e2b3b635cdf2d8dfef3754d3 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.07e-04 | 189 | 58 | 4 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 1.07e-04 | 189 | 58 | 4 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 189 | 58 | 4 | ce5b3d53c9a5457a5a02b221dee18334b5eaf8b7 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 189 | 58 | 4 | 324c81285c51f4f8bb1aef428b18fe2c549c2c11 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 189 | 58 | 4 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 191 | 58 | 4 | c21e7904e06a5c90176f935f6822dbb5a1aa6755 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 191 | 58 | 4 | 48823a97c38263f2c6e58348214f5b62773a6368 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-04 | 191 | 58 | 4 | 80484d39f34703a33b9bac09826b7a526e883cab | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-04 | 191 | 58 | 4 | 5c4e4e9de14edfae072a2a2882220a31bebf51b2 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-04 | 191 | 58 | 4 | 9c0ee270209b02043393416ecc9a81ddedfbb8b6 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 191 | 58 | 4 | 0eedc66e967b1837ce2c14f8c14b3c1eba868c76 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-04 | 192 | 58 | 4 | aedddccacf60e884af044cefba6c64ca10ac97d2 | |
| Drug | propoxyphene | 1.85e-08 | 67 | 58 | 6 | CID000010100 | |
| Drug | carteolol | 2.87e-08 | 72 | 58 | 6 | CID000002583 | |
| Drug | trimipramine | 5.44e-08 | 80 | 58 | 6 | CID000005584 | |
| Drug | aminoglutethimide | 5.70e-08 | 137 | 58 | 7 | CID000002145 | |
| Drug | dichloran | 6.28e-08 | 41 | 58 | 5 | CID000007430 | |
| Drug | diosmetin | 7.84e-08 | 85 | 58 | 6 | CID005281612 | |
| Drug | halothane | CACNA1E NCOA6 CYP4F8 CYP4B1 CYP4F2 CYP4F3 CYP4F12 PLCH1 CYP4F11 | 9.47e-08 | 314 | 58 | 9 | CID000003562 |
| Drug | mephenytoin | 9.66e-08 | 88 | 58 | 6 | CID000004060 | |
| Drug | tienilic acid | 1.35e-07 | 93 | 58 | 6 | CID000038409 | |
| Drug | lansoprazole | 1.35e-07 | 93 | 58 | 6 | CID000003883 | |
| Drug | AC1L1KIN | 2.08e-07 | 100 | 58 | 6 | CID000005516 | |
| Drug | Sparteinum | 2.20e-07 | 101 | 58 | 6 | CID000003966 | |
| Drug | felodipine | 2.40e-07 | 169 | 58 | 7 | CID000003333 | |
| Drug | ebastine | 4.61e-07 | 25 | 58 | 4 | CID000003191 | |
| Drug | AC1Q7AUJ | 5.27e-07 | 117 | 58 | 6 | CID000003303 | |
| Drug | 8-MOP | 5.54e-07 | 118 | 58 | 6 | CID000004114 | |
| Drug | C14845 | 6.37e-07 | 27 | 58 | 4 | CID011954064 | |
| Drug | BP-9,10-oxide | 6.37e-07 | 27 | 58 | 4 | CID000037456 | |
| Drug | Brn 4136738 | 6.37e-07 | 27 | 58 | 4 | CID000050331 | |
| Drug | 9-OH-BaP-4,5-oxide | 7.41e-07 | 28 | 58 | 4 | CID000115064 | |
| Drug | hexobarbital | 8.54e-07 | 127 | 58 | 6 | CID000003608 | |
| Drug | chloral hydrate | 9.36e-07 | 129 | 58 | 6 | CID000002707 | |
| Drug | 4-bromophenol | 9.59e-07 | 70 | 58 | 5 | CID000007808 | |
| Drug | 11-H-14,15-EETA | 9.89e-07 | 30 | 58 | 4 | CID011954058 | |
| Drug | 19-hydroxytestosterone | 9.89e-07 | 30 | 58 | 4 | CID000150968 | |
| Drug | diclofenac | 1.00e-06 | 209 | 58 | 7 | CID000003032 | |
| Drug | BP-7,8-oxide | 1.29e-06 | 32 | 58 | 4 | CID000037455 | |
| Drug | 12(13)-EpOME | 1.66e-06 | 34 | 58 | 4 | CID000001416 | |
| Drug | TCEO | 1.66e-06 | 34 | 58 | 4 | CID000028167 | |
| Drug | AC1O5XSP | 1.66e-06 | 34 | 58 | 4 | CID006442739 | |
| Drug | 18-HETE | 1.86e-06 | 10 | 58 | 3 | CID006442778 | |
| Drug | AC1L1CJI | 1.87e-06 | 35 | 58 | 4 | CID000001929 | |
| Drug | 15-H-11,12-EETA | 2.10e-06 | 36 | 58 | 4 | CID011954042 | |
| Drug | AC1L3NGJ | 2.10e-06 | 36 | 58 | 4 | CID000092121 | |
| Drug | 3 -hydroxypregn-5-en-20-one | 2.39e-06 | 238 | 58 | 7 | CID000001027 | |
| Drug | 11,14,15-THET | 2.92e-06 | 39 | 58 | 4 | CID006439531 | |
| Drug | AC1O5PIQ | 2.92e-06 | 39 | 58 | 4 | CID006438348 | |
| Drug | 6-trans-leukotriene B4 | 3.05e-06 | 247 | 58 | 7 | CID000000169 | |
| Drug | paraoxon | 3.78e-06 | 164 | 58 | 6 | CID000009395 | |
| Drug | 11,12,15-trihydroxyeicosatrienoic acid | 3.95e-06 | 42 | 58 | 4 | CID006439610 | |
| Drug | azo analog I | 4.41e-06 | 13 | 58 | 3 | CID006438575 | |
| Drug | aminopyrine | 4.81e-06 | 171 | 58 | 6 | CID000006009 | |
| Drug | naphthalene-1,2-dihydrodiol | 5.22e-06 | 45 | 58 | 4 | CID000000362 | |
| Drug | C14802 | 6.23e-06 | 47 | 58 | 4 | CID011954053 | |
| Drug | metyrapone | 6.26e-06 | 179 | 58 | 6 | CID000004174 | |
| Drug | C14800 | 6.78e-06 | 48 | 58 | 4 | CID011954051 | |
| Drug | nitro-L | 6.78e-06 | 48 | 58 | 4 | CID000006849 | |
| Drug | diamidine | 6.98e-06 | 15 | 58 | 3 | CID000008813 | |
| Drug | 19-HETE | 7.37e-06 | 49 | 58 | 4 | CID006439528 | |
| Drug | bromobenzene-3,4-oxide | 7.37e-06 | 49 | 58 | 4 | CID000108121 | |
| Drug | bromobenzene-2,3-oxide | 8.00e-06 | 50 | 58 | 4 | CID003036760 | |
| Drug | 6-hydroxymelatonin | 8.00e-06 | 50 | 58 | 4 | CID000001864 | |
| Drug | 1,1-dichloroethylene epoxide | 8.00e-06 | 50 | 58 | 4 | CID000119521 | |
| Drug | naphthalene epoxide | 8.66e-06 | 51 | 58 | 4 | CID000108063 | |
| Drug | alprazolam | 9.63e-06 | 193 | 58 | 6 | CID000002118 | |
| Drug | nifedipine | 9.84e-06 | 415 | 58 | 8 | CID000004485 | |
| Drug | 9-hydroxybenzo(a)pyrene | 1.01e-05 | 53 | 58 | 4 | CID000028598 | |
| Drug | dichloroacetaldehyde | 1.09e-05 | 54 | 58 | 4 | CID000006576 | |
| Drug | tolbutamide | 1.11e-05 | 198 | 58 | 6 | CID000005505 | |
| Drug | chloroacetyl chloride | 1.17e-05 | 55 | 58 | 4 | CID000006577 | |
| Drug | benzphetamine | 1.32e-05 | 119 | 58 | 5 | CID000002341 | |
| Drug | 1,2-dihydroxynaphthalene | 1.35e-05 | 57 | 58 | 4 | CID000011318 | |
| Drug | bromoacetaldehyde | 1.45e-05 | 58 | 58 | 4 | CID000105131 | |
| Drug | 1,1-dichloroethylene | 1.66e-05 | 60 | 58 | 4 | CID000006366 | |
| Drug | 17-ODYA | 1.66e-05 | 60 | 58 | 4 | CID000001449 | |
| Drug | BP-4,5-oxide | 1.78e-05 | 61 | 58 | 4 | CID000037786 | |
| Drug | NSC98537 | 2.52e-05 | 473 | 58 | 8 | CID000005410 | |
| Drug | deferoxamine | 2.58e-05 | 343 | 58 | 7 | CID000002973 | |
| Drug | piperonyl butoxide | 2.58e-05 | 67 | 58 | 4 | CID000005794 | |
| Drug | 5,6-epoxyeicosatrienoic acid | 2.73e-05 | 68 | 58 | 4 | CID000001778 | |
| Drug | dioxin | 2.77e-05 | 347 | 58 | 7 | CID000015625 | |
| Drug | 8(9)-EET | 2.90e-05 | 69 | 58 | 4 | CID000001901 | |
| Drug | LS-63783 | CYP4F8 CYP4B1 NR4A2 DGKI CDK5RAP2 CYP4F2 CYP4F3 CYP4F12 MMP2 CYP4F11 | 3.20e-05 | 804 | 58 | 10 | CID000000231 |
| Drug | beta-NADP | 3.24e-05 | 490 | 58 | 8 | CID000000929 | |
| Drug | 1,2-dibromoethane | 3.24e-05 | 71 | 58 | 4 | CID000007839 | |
| Drug | 2,2,2-trichloroethanol | 3.62e-05 | 73 | 58 | 4 | CID000008259 | |
| Drug | chloral | 3.62e-05 | 73 | 58 | 4 | CID000006407 | |
| Drug | hydride | CACNA1E NCOA6 CYP4F8 CYP4B1 CYP4F2 CYP4F12 AQP8 ALDH6A1 CYP4F11 KMO | 4.41e-05 | 835 | 58 | 10 | CID000000783 |
| Drug | AC1L1HMM | 4.67e-05 | 516 | 58 | 8 | CID000004196 | |
| Drug | C20H32O4 | 4.70e-05 | 78 | 58 | 4 | CID000001440 | |
| Drug | BP-7,8-diol | 4.70e-05 | 78 | 58 | 4 | CID000025892 | |
| Drug | NADP(H | 5.42e-05 | 527 | 58 | 8 | CID000000930 | |
| Drug | bromide | 5.97e-05 | 267 | 58 | 6 | CID000000259 | |
| Drug | NIPS | 7.38e-05 | 32 | 58 | 3 | CID000196875 | |
| Drug | trichloroethylene | 7.54e-05 | 88 | 58 | 4 | CID000006575 | |
| Drug | 14(15)-EpETrE | 7.88e-05 | 89 | 58 | 4 | CID000001431 | |
| Drug | caffeine | 8.49e-05 | 562 | 58 | 8 | CID000002519 | |
| Drug | parathion | 8.59e-05 | 91 | 58 | 4 | CID000000991 | |
| Drug | 2-naphthol | 9.35e-05 | 93 | 58 | 4 | CID000008663 | |
| Drug | AC1L1BEQ | 9.35e-05 | 93 | 58 | 4 | CID000001407 | |
| Drug | Ro 31-8425 | 9.50e-05 | 6 | 58 | 2 | ctd:C071924 | |
| Drug | bromobenzene | 1.10e-04 | 97 | 58 | 4 | CID000007961 | |
| Drug | propafenone | 1.15e-04 | 98 | 58 | 4 | CID000004932 | |
| Drug | rifampicin | 1.26e-04 | 306 | 58 | 6 | CID005381226 | |
| Drug | 3-hydroxystearate | 1.33e-04 | 7 | 58 | 2 | CID005282907 | |
| Drug | clofibrate | 1.38e-04 | 311 | 58 | 6 | CID000002796 | |
| Drug | Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; HL60; HT_HG-U133A | 1.42e-04 | 196 | 58 | 5 | 2547_UP | |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Up 200; 5.8uM; PC3; HT_HG-U133A | 1.42e-04 | 196 | 58 | 5 | 4508_UP | |
| Drug | AC1Q6O8T | 1.46e-04 | 197 | 58 | 5 | CID000002193 | |
| Drug | Sulfadiazine [68-35-9]; Up 200; 16uM; PC3; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 5098_UP | |
| Disease | Schizophrenia | 5.60e-06 | 883 | 56 | 10 | C0036341 | |
| Disease | Autism Spectrum Disorders | 2.10e-05 | 85 | 56 | 4 | C1510586 | |
| Disease | hypertension (biomarker_via_orthology) | 7.16e-05 | 227 | 56 | 5 | DOID:10763 (biomarker_via_orthology) | |
| Disease | Gastrointestinal Hemorrhage | 1.26e-04 | 9 | 56 | 2 | C0017181 | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 1.26e-04 | 9 | 56 | 2 | EFO_0800562 | |
| Disease | Autistic Disorder | 1.38e-04 | 261 | 56 | 5 | C0004352 | |
| Disease | Retinal Detachment | 1.92e-04 | 11 | 56 | 2 | C0035305 | |
| Disease | intracranial aneurysm (is_implicated_in) | 2.31e-04 | 12 | 56 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 2.72e-04 | 13 | 56 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | schizophrenia (implicated_via_orthology) | 2.97e-04 | 68 | 56 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | intracranial aneurysm (is_marker_for) | 3.17e-04 | 14 | 56 | 2 | DOID:10941 (is_marker_for) | |
| Disease | Osteopenia | 3.66e-04 | 15 | 56 | 2 | C0029453 | |
| Disease | feeling nervous measurement | 6.13e-04 | 87 | 56 | 3 | EFO_0009597 | |
| Disease | carotid artery disease (is_implicated_in) | 7.98e-04 | 22 | 56 | 2 | DOID:3407 (is_implicated_in) | |
| Disease | brain ischemia (biomarker_via_orthology) | 9.73e-04 | 102 | 56 | 3 | DOID:2316 (biomarker_via_orthology) | |
| Disease | cortical thickness | 1.14e-03 | 1113 | 56 | 8 | EFO_0004840 | |
| Disease | Major Depressive Disorder | 1.18e-03 | 243 | 56 | 4 | C1269683 | |
| Disease | depressive symptom measurement | 1.28e-03 | 426 | 56 | 5 | EFO_0007006 | |
| Disease | ganglion cell inner plexiform layer thickness measurement | 1.30e-03 | 28 | 56 | 2 | EFO_0600005 | |
| Disease | Unipolar Depression | 1.49e-03 | 259 | 56 | 4 | C0041696 | |
| Disease | neuroticism measurement | 1.60e-03 | 909 | 56 | 7 | EFO_0007660 | |
| Disease | Alcoholic Intoxication, Chronic | 1.69e-03 | 268 | 56 | 4 | C0001973 | |
| Disease | facial morphology measurement | 1.89e-03 | 466 | 56 | 5 | EFO_0007841 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CFMNNSGILEGFDPP | 251 | Q15878 | |
| FPGMGFIFRNCPSNP | 391 | Q9C073 | |
| GGCMNPARAFGPAVV | 206 | O94778 | |
| GCSMNPARSFGPAVV | 181 | P55064 | |
| LSCMGFQGNGFPDRL | 681 | Q96SN8 | |
| TMGGNAEGQPCKFPF | 281 | P08253 | |
| LGVCAGIAPFNFPAM | 176 | Q02252 | |
| FGFCNGMVVHPQNPL | 1191 | P10071 | |
| YPGGARNPMACNGSA | 16 | Q9HB89 | |
| TPVSGFGFRCPQEMF | 81 | Q4VC12 | |
| LVLNFGSCTUPPFMA | 161 | P55073 | |
| VAQGGSFPCFGMPWN | 221 | Q8NDZ0 | |
| SFPCFGMPWNFISGG | 226 | Q8NDZ0 | |
| NQDTCSPFAGMLFGG | 396 | Q1MSJ5 | |
| NTFPPRSSGCFPNMA | 451 | Q96I24 | |
| ADLPGSPVSNNFMGC | 436 | Q9P2S2 | |
| DLPGSPVSNNFMGCL | 391 | Q9Y4C0 | |
| APSGNFVACGGLDNM | 106 | P16520 | |
| IACMAPGNFPGANFT | 36 | A8MVS5 | |
| FVCATTGQGDPPDNM | 56 | Q9UHB4 | |
| ANELMGFNDSSPGCP | 41 | P41586 | |
| IAPPAGTGCVNFMAT | 146 | P78509 | |
| FFSQPGAPILQCMGC | 41 | P01215 | |
| PFSGAPNGNQMSCGQ | 856 | Q14686 | |
| GFADLMGSNGPQKFC | 841 | Q96J02 | |
| GFQLNPAGCAFFLDM | 36 | Q9H6K1 | |
| PFFGQGMNAGFEDCL | 311 | O15229 | |
| ACAPSAAAGAGAMNP | 41 | O75912 | |
| RKGPFFGLACFANMP | 126 | A4D1U4 | |
| FSAGPRNCIGQAFAM | 461 | Q9HBI6 | |
| PFGCGEQNMIHFAPN | 1141 | Q8IZJ3 | |
| MAFIPFSAGPRNCIG | 456 | P98187 | |
| FSAGPRNCIGQAFAM | 461 | Q9HCS2 | |
| FLNAIFPNGAAYCMG | 136 | P17707 | |
| QPCPPDTQGNMGFSC | 121 | Q8IZF7 | |
| TDPHPGLQGGCMFFN | 546 | Q86UW7 | |
| FSAGPRNCIGQTFAM | 461 | P78329 | |
| FCDANNLMFIPSVGP | 346 | Q5VSG8 | |
| TEGSFQCVCPMGFQP | 771 | Q8N2S1 | |
| QCVCPMGFQPNTAGS | 776 | Q8N2S1 | |
| ATVPAAPMQLFNGGC | 71 | Q8WUP2 | |
| FAFMPFSAGPRNCIG | 441 | P13584 | |
| FSAGPRNCIGQQFAM | 446 | P13584 | |
| FSAGPRNCIGQAFAM | 461 | Q08477 | |
| CAFQNSFLGGLPVGM | 606 | P82279 | |
| TAMQPACSAAGGGPF | 311 | Q8TAU0 | |
| GPVPSFAFSQNDMCL | 721 | Q5SV97 | |
| MGCPGQEPALFSTDN | 56 | P22223 | |
| MPCVQAQYGSSPQGA | 1 | P43354 | |
| CGPSGAGASNVFVQM | 121 | Q5VT03 | |
| GAVFEGCGMTPNANP | 266 | Q9NP81 | |
| FFAAPMPGDCPAAGT | 236 | Q9H6I2 | |
| SVPMQAFPCCLSGFN | 1626 | O60522 | |
| MFFPCANPPGAVVGL | 446 | Q9Y289 | |
| EMFLNFGQCGPPASL | 1711 | Q7Z333 | |
| APQMAPAFAAFPAFG | 236 | O95081 | |
| GMNDPDFGYSQGNPC | 156 | P54709 | |
| APPAGFQMAPCGCFF | 61 | Q8IZ63 | |
| QFGGCVMFHAPVPGA | 2436 | Q86WI1 | |
| NPAPLNGGAFCEGMS | 281 | Q6UXZ4 | |
| QQMCKGTFNPFSGDP | 711 | Q4KWH8 | |
| SMFFNGQPSPGQRLC | 461 | Q96JG9 | |
| MPVGPLQGGFCANSN | 691 | Q8WYQ9 |